A Study to Test if SAR443809 is Tolerated and Safe When Taken as a Single Dose in Healthy Adults
Status:
COMPLETED
Trial end date:
2023-05-05
Target enrollment:
Participant gender:
Summary
Primary objective
* The tolerability and safety of SAR443809 Secondary
* The PK parameters of SAR443809
* The PD activity of SAR443809
* The immunogenicity of SAR443809